ClinicalTrials.govpublic full text
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
esophageal squamous cell carcinoma, ifinatamab deruxtecan (i-dxd), ds-7300a, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 900781
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.